Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 3/20 | 0.58 |
| ▸ | CA2 | P00918 | 3/20 | 0.58 |
| ▸ | CA7 | P43166 | 2/20 | 0.58 |
| ▸ | CA9 | Q16790 | 2/20 | 0.58 |
| ▸ | CA12 | O43570 | 1/20 | 0.58 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.58 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.57 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.57 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.57 |
| ▸ | TDP1 | Q9NUW8 | 4/20 | 0.52 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.52 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.52 |
| ▸ | TSHR | P16473 | 1/20 | 0.52 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.50 |
| ▸ | AOC3 | Q16853 | 3/20 | 0.48 |
| ▸ | SLC2A1 | P11166 | 1/20 | 0.48 |
| ▸ | ACHE | P22303 | 2/20 | 0.48 |
| ▸ | MAOA | P21397 | 2/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL591062 | 1.00 | CA1 (0.58) | CA1CA2CA7CA9CA12 | |
| SCHEMBL1900477 | 1.00 | CA1 (0.58) | CA1CA2CA7CA9CA12 | |
| SCHEMBL1900910 | 1.00 | CA1 (0.58) | CA1CA2CA7CA9CA12 | |
| Hydrochloric Acid SCHEMBL14119724 | 0.97 | CYP1A2 (0.55) | CA1CA2CA7CA9CA12 | |
| Hydrochloric Acid SCHEMBL19951722 | 0.97 | CYP1A2 (0.55) | CA1CA2CA7CA9CA12 | |
| Hydrochloric Acid SCHEMBL30098259 | 0.97 | CYP1A2 (0.55) | CA1CA2CA7CA9CA12 | |
| SCHEMBL3253569 | 0.91 | DPP4 (0.61) | CA1CA2CA7CA9CA12 | |
| SCHEMBL10868139 | 0.91 | TDP1 (0.50) | CA1CA2CA7CA9CA12 | |
| SCHEMBL10866506 | 0.91 | TDP1 (0.50) | CA1CA2CA7CA9CA12 | |
| SCHEMBL13298408 | 0.91 | DPP4 (0.61) | CA1CA2CA7CA9CA12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 85 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6989052-B1 | Phase change ink printing process | XEROX CORPORATION (US) | 2006-01-24 | — | — | US | claimed |
| US-20060004123-A1 | PHASE CHANGE INK PRINTING PROCESS | XEROX CORPORATION | 2006-01-05 | — | — | US | claimed |
| JP-5018977-A | — | — | None | — | — | JP | disclosed |
| CN-115023457-B | (Poly) rotaxane and method for producing same, curable composition, cured product, article, and composition | 株式会社ASM | 2024-09-24 | — | — | CN | disclosed |
| CN-115023457-A | (Poly) rotaxane, method for producing same, curable composition, cured product, article, and composition | 株式会社ASM | 2022-09-06 | — | — | CN | disclosed |
| CN-112663168-B | Spandex fiber with reversible shape memory effect and preparation method and application thereof | 五邑大学 | 2022-07-19 | — | — | CN | disclosed |
| CN-112962165-B | Spandex fiber with reversible three-shape memory effect and preparation method and application thereof | 五邑大学 | 2022-07-05 | — | — | CN | disclosed |
| US-20220169600-A1 | METHOD FOR PRODUCING PKROSTAGLANDIN | KYOWA PHARMA CHEMICAL CO., LTD. (JP) | 2022-06-02 | — | — | US | disclosed |
| EP-3950672-A1 | METHOD FOR PRODUCING PKROSTAGLANDIN | Kyowa Pharma Chemical Co., Ltd. (JP) | 2022-02-09 | — | — | EP | disclosed |
| WO-2021223156-A1 | DIBORON GLYCOL ESTER, PREPARATION METHOD THEREFOR, INTERMEDIATE THEREOF, AND APPLICATION THEREOF | 中国科学院上海有机化学研究所 | 2021-11-11 | — | — | WO | disclosed |
| US-10189871-B2 | Transition metal complexes for enantioselective catalysis of carbon-carbon, carbon-heteroatom, and carbon-hydrogen bond forming reactions | THE TEXAS A&M UNIVERSITY SYSTEM (US) | 2019-01-29 | — | — | US | disclosed |
| EP-0116955-B1 | COMPLEXES OF (1,2-DIPHENYL-ETHYLENE DIAMINE) PLATINUM (II) | Degussa Aktiengesellschaft (DE) | 1987-05-20 | — | — | EP | disclosed |
| EP-0193055-A1 | Antitumorals(1,2-diphenyl-ethylene diamine)-platinum (II) complexes | ASTA Pharma AG (DE) | 1986-09-03 | — | — | EP | disclosed |
| US-4598091-A | (1,2-diphenyl)-ethylenediamine)-platinum (II) complex compounds | DEGUSSA AKTIENGESELLSCHAFT (DE) | 1986-07-01 | — | — | US | disclosed |
| EP-0045081-B1 | TRISUBSTITUTED IMIDAZOLE DERIVATIVES, PROCESSES FOR PREPARING THEM, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, AND THEIR USE | CIBA-GEIGY AG (CH) | 1986-01-08 | — | — | EP | disclosed |
| EP-0116955-A2 | Complexes of (1,2-diphenyl-ethylene diamine) platinum (II) | Degussa Aktiengesellschaft (DE) | 1984-08-29 | — | — | EP | disclosed |
| US-4447431-A | VIRICIDES, ANTIINFLAMMATORY AND SUNCREEN AGENT | CIBA-GEIGY CORPORATION (US) | 1984-05-08 | — | — | US | disclosed |
| US-4353918-A | ANTIINFLAMMATORY, ANTIRHEUMATIC | CIBA-GEIGY CORPORATION (US) | 1982-10-12 | — | — | US | disclosed |
| EP-0046451-A2 | Diaryl-imidazole compounds, methods for their preparation, pharmaceutical drugs containing them and their use | CIBA-GEIGY AG (CH) | 1982-02-24 | — | — | EP | disclosed |
| EP-0045081-A2 | Trisubstituted imidazole derivatives, processes for preparing them, pharmaceutical compositions containing them, and their use | CIBA-GEIGY AG (CH) | 1982-02-03 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10189871-B2 | Transition metal complexes for enantioselective catalysis of carbon-carbon, carbon-heteroatom, and carbon-hydrogen bond forming reactions | SOD1, YWHAZ, L1CAM | CA1 161/4885CA2 172/4885CA7 1107/4885 |
| US-20220169600-A1 | METHOD FOR PRODUCING PKROSTAGLANDIN | PTGS1, PTGER1, RACK1 | CA1 2612/4885CA2 1309/4885CA7 2998/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.